Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Grant

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
International Journal of Cancer|July 15, 1974
Sensitization to tumour-associated antigens in human breast carcinomaA J Cochran, R M Grant, W G Spilg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2000
Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapyS S Huang, J D Barbour, S G Deeks, et al.
AIDS (London, England)|July 9, 1999
Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infectionS Staprans, N Marlowe, D Glidden, et al.
Lancet (London, England)|May 11, 1974
Lymphocytes with T and B cell properties in a lymphoproliferative disorderG P Sandilands, K Gray, A Cooney, et al.
British Journal of Cancer|May 28, 2009
Suspected malignant cord compression - improving time to diagnosis via a 'hotline': a prospective auditL Allan, L Baker, J Dewar, et al.
The Yale Journal of Biology and Medicine|December 1, 1973
Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatmentA J Cochran, C E Thomas, W G Spilg, et al.
Clinical and Diagnostic Laboratory Immunology|March 1, 1995
Hematological reference ranges among healthy UgandansS B Tugume, E M Piwowar, T Lutalo, et al.
The New England Journal of Medicine|February 2, 1989
Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndromeK S Erlich, J Mills, P Chatis, et al.
Clinical and Vaccine Immunology : CVI|September 26, 2008
Potentially exposed but uninfected individuals produce cytotoxic and polyfunctional human immunodeficiency virus type 1-specific CD8(+) T-cell responses which can be defined to the epitope levelA L Erickson, C B Willberg, V McMahan, et al.
The British Journal of Surgery|November 1, 1973
Proceedings: cellular immunity to malignant melanomaR M Grant, A J Cochran, C E Thomas, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|July 15, 1974
Sensitization to tumour-associated antigens in human breast carcinomaA J Cochran, R M Grant, W G Spilg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2000
Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapyS S Huang, J D Barbour, S G Deeks, et al.
AIDS (London, England)|July 9, 1999
Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infectionS Staprans, N Marlowe, D Glidden, et al.
Lancet (London, England)|May 11, 1974
Lymphocytes with T and B cell properties in a lymphoproliferative disorderG P Sandilands, K Gray, A Cooney, et al.
British Journal of Cancer|May 28, 2009
Suspected malignant cord compression - improving time to diagnosis via a 'hotline': a prospective auditL Allan, L Baker, J Dewar, et al.
The Yale Journal of Biology and Medicine|December 1, 1973
Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatmentA J Cochran, C E Thomas, W G Spilg, et al.
Clinical and Diagnostic Laboratory Immunology|March 1, 1995
Hematological reference ranges among healthy UgandansS B Tugume, E M Piwowar, T Lutalo, et al.
The New England Journal of Medicine|February 2, 1989
Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndromeK S Erlich, J Mills, P Chatis, et al.
Clinical and Vaccine Immunology : CVI|September 26, 2008
Potentially exposed but uninfected individuals produce cytotoxic and polyfunctional human immunodeficiency virus type 1-specific CD8(+) T-cell responses which can be defined to the epitope levelA L Erickson, C B Willberg, V McMahan, et al.
The British Journal of Surgery|November 1, 1973
Proceedings: cellular immunity to malignant melanomaR M Grant, A J Cochran, C E Thomas, et al.
Pageof 7